Comparative responses of rats and mice exposed to linear/branched, linear, or branched ammonium perfluorooctanoate (APFO).

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Toxicology

• Publication date

  2006-03-15

• Fields of study

  Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1016/J.TOX.2006.01.003PMID 16448737
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Quantitative determination of perfluorooctanoic acid in serum and plasma by liquid chromatography tandem mass spectrometry.

  2005cited by this paper
• The Toxicology of Perfluorooctanoate

  2004cited by this paper
• Characterization of risk for general population exposure to perfluorooctanoate.

  2004cited by this paper
• Epidemiologic Assessment of Worker Serum Perfluorooctanesulfonate (PFOS) and Perfluorooctanoate (PFOA) Concentrations and Medical Surveillance Examinations

  2003cited by this paper
• The relationship between liver peroxisome proliferation and adipose tissue atrophy induced by peroxisome proliferator exposure and withdrawal in mice.

  2003cited by this paper
• Toxicity and toxicokinetics of perfluorooctanoic acid in humans and animals.

  2003cited by this paper
• Human donor liver and serum concentrations of perfluorooctanesulfonate and other perfluorochemicals.

  2003cited by this paper
• Dose-response modeling of continuous endpoints.

  2002cited by this paper
• Toxicity of ammonium perfluorooctanoate in male cynomolgus monkeys after oral dosing for 6 months.

  2002cited by this paper
• Compound-specific, quantitative characterization of organic fluorochemicals in biological matrices.

  2001cited by this paper
• PLASMA CHOLECYSTOKININ AND HEPATIC ENZYMES, CHOLESTEROL AND LIPOPROTEINS IN AMMONIUM PERFLUOROOCTANOATE PRODUCTION WORKERS

  2000cited by this paper
• trans-activation of PPARα and PPARγ by structurally diverse environmental chemicals

  1999cited by this paper
• trans-Activation of PPARalpha and PPARgamma by structurally diverse environmental chemicals.

  1999cited by this paper
• Mechanisms of peroxisome proliferation by perfluorooctanoic acid and endogenous fatty acids.

  1998cited by this paper
• A new model function for continuous data sets in health risk assessment of chemicals using the benchmark dose concept.

  1998cited by this paper
• An epidemiologic investigation of reproductive hormones in men with occupational exposure to perfluorooctanoic acid.

  1998cited by this paper
• Added risk and inverse estimation for count responses in reproductive aquatic toxicology studies.

  1998cited by this paper
• Characterization of hepatic responses of rat to administration of perfluorooctanoic and perfluorodecanoic acids at low levels.

  1995cited by this paper
• The mechanism underlying the hypolipemic effect of perfluorooctanoic acid (PFOA), perfluorooctane sulphonic acid (PFOSA) and clofibric acid.

  1992cited by this paper
• Tissue distribution, metabolism, and elimination of perfluorooctanoic acid in male and female rats.

  1991cited by this paper
• Cholestyramine-enhanced fecal elimination of carbon-14 in rats after administration of ammonium [14C]perfluorooctanoate or potassium [14C]perfluorooctanesulfonate.

  1984cited by this paper
• Assay of peroxisomal beta-oxidation of fatty acids.

  1981cited by this paper
• Pairwise Multiple Comparisons in the Unequal Variance Case

  1980cited by this paper
• Health status of plant workers exposed to fluorochemicals--a preliminary report.

  1980cited by this paper
• Biochemistry Involving Carbon-Fluorine Bonds

  1976cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper
• STATISTICAL METHODS

  1967cited by this paper
• An Analysis of Variance Test for Normality (Complete Samples)

  1965cited by this paper
• Multiple Comparisons Using Rank Sums

  1964cited by this paper
• New tables for multiple comparisons with a control.

  1964cited by this paper
• Contributions to Probability and Statistics

  1960cited by this paper
• Use of Ranks in One-Criterion Variance Analysis

  1952cited by this paper

• ROS-Driven Rewiring of Hippo-Inflammation-Polycomb Axis by PFOA in 2D and 3D Lung Epithelial Models.

  2026cites this paper
• Isomer-specific binding affinity of perfluoroalkyl substances with red blood cells.

  2026cites this paper
• PFAS Isomers Matter: Distribution Patterns of Linear and Branched PFOS and PFOA in Consumed Fish Revealed by Cyclic Ion Mobility Separation.

  2025cites this paper
• Range of the perfluorooctanoate (PFOA) safe dose for human health: an international collaboration

  2025cites this paper
• Maternal PFAS Transfer through Lactation: Dolphin Milk Reveals Routes of Early-Life Exposure

  2025cites this paper
• Identification of four mechanisms of toxicity for per- and polyfluoroalkyl substances through transcriptomic profiling in human liver spheroids exposed to 24 PFAS

  2025cites this paper
• Effects of perfluorooctanoic acid exposure and heat stress on performance and liver health biomarkers in post-pubertal gilts

  2025cites this paper
• Dehydroxy-Perfluoro-tert-butylation of alcohols with PhSO2C(CF3)3 and insights into the structure of the [C(CF3)3]− anion

  2025cites this paper
• Perfluorooctanoic acid increases serum cholesterol in a PPARα-dependent manner in female mice

  2025cites this paper
• A systems toxicology approach for identification of disruptions in cholesterol homeostasis after aggregated exposure to mixtures of perfluorinated compounds (PFAS) in humans.

  2024cites this paper
• Assessment of the Variability in the Occurrence of PFAS in Fish Tissues from Selected Fisheries in the Baltic Sea

  2024cites this paper
• Mode of Action Criteria for Selection of the Critical Effect and Safe Dose Range for PFOA by the Alliance for Risk Assessment.

  2024cites this paper
• Sex and obesity influence the relationship between perfluoroalkyl substances and lean body mass: NHANES 2011–2018

  2024cites this paper
• General toxicity and screening of reproductive and developmental toxicity following bioaccumulation of oral-dosed perfluorooctanoic acid: Loss of the Golgi apparatus.

  2024cites this paper
• Surface Science View of Perfluoroalkyl Acids (PFAAs) in the Environment

  2024cites this paper
• Environmental Obesogens and Their Perturbations in Lipid Metabolism

  2024cites this paper
• Perfluorooctanoic acid-induced cell death via the dual roles of ROS-MAPK/ERK signaling in ameloblast-lineage cells

  2023cites this paper
• A Machine Learning Model to Estimate Toxicokinetic Half-Lives of Per- and Polyfluoro-Alkyl Substances (PFAS) in Multiple Species

  2023cites this paper
• PFOA exposure induces aberrant glucose and lipid metabolism in the rat liver through the AMPK/mTOR pathway.

  2023cites this paper
• Range of the perfluorooctanoate (PFOA) safe dose for human health: An international collaboration.

  2023influential citation
• Dose Response, Dosimetric, and Metabolic Evaluations of Replacement PFAS Perfluoro-(2,5,8-trimethyl-3,6,9-trioxadodecanoic) Acid (HFPO-TeA)

  2023influential citation
• Per- and polyfluoroalkyl substances (PFAS) in grocery store foods: method optimization, occurrence, and exposure assessment.

  2023cites this paper
• An Integrated Approach for Determination of Total Per- and Polyfluoroalkyl Substances (PFAS).

  2022cites this paper
• Exposure of Preconception Couples to Legacy and Emerging Per- and Polyfluoroalkyl Substances: Variations Within and Between Couples.

  2022cites this paper
• PFAS Experts Symposium 2: PFAS Toxicology and Risk Assessment in 2021 and risk assessment in 2021—Contemporary issues in human and ecological risk assessment of PFAS

  2022cites this paper
• Changes in plasma levels of per- and polyfluoroalkyl substances (PFAS) are associated with changes in plasma lipids - A longitudinal study over 10 years.

  2022cites this paper
• Identification of Branched and Linear Forms of PFOA and Potential Precursors: A User-Friendly SMILES Structure-based Approach

  2022cites this paper
• Exposure to low-dose perfluorooctanoic acid promotes hepatic steatosis and disrupts the hepatic transcriptome in mice

  2022cites this paper
• Apparent Half-Lives of Chlorinated-Perfluorooctane Sulfonate and Perfluorooctane Sulfonate Isomers in Aviation Firefighters.

  2022cites this paper
• On-line solid phase extraction-ultra high performance liquid chromatography-quadrupole/Orbitrap high resolution mass spectrometry determination of per- and polyfluoroalkyl substances in human serum.

  2022cites this paper
• Molecular Screening and Toxicity Estimation of 260, 000 Perfluoroalkyl and Polyfluoroalkyl Substances (PFASs) through Machine Learning

  2022cites this paper
• Perfluorooctanoic Acid Induces Liver and Serum Dyslipidemia in Humanized PPARα Mice fed an American Diet

  2021cites this paper
• Half-lives of several polyfluoroalkyl substances (PFAS) in cattle serum and tissues

  2021cites this paper
• Exposure to a mixture of legacy, alternative, and replacement per- and polyfluoroalkyl substances (PFAS) results in sex-dependent modulation of cholesterol metabolism and liver injury.

  2021cites this paper
• The Dilemma of Perfluorooctanoate (PFOA) Human Half-life.

  2021cites this paper
• Characterization of PFOS toxicity on in-vivo and ex-vivo mouse pancreatic islets.

  2021cites this paper
• Why is elevation of serum cholesterol associated with exposure to perfluoroalkyl substances (PFAS) in humans? A workshop report on potential mechanisms

  2021cites this paper
• Enhanced Recovery of Per- and Polyfluoroalkyl Substances (PFASs) from Impacted Soils Using Heat Activated Persulfate.

  2021cites this paper
• Perfluorooctanoic acid (PFOA) induces behavioural, reproductive and developmental toxicological impacts in Caenorhabditis elegans at concentrations relevant to the contaminated areas

  2021cites this paper
• Systemic PFOS and PFOA exposure and disturbed lipid homeostasis in humans: what do we know and what not?

  2021influential citation
• Resolving unknown isomers of emerging per- and polyfluoroalkyl substances (PFASs) in environmental samples using COSMO-RS-derived retention factor and mass fragmentation patterns.

  2020cites this paper
• An evaluation of health-based federal and state PFOA drinking water guidelines in the United States.

  2020cites this paper
• Diet as an Exposure Source and Mediator of Per- and Polyfluoroalkyl Substance (PFAS) Toxicity

  2020cites this paper
• Per- and polyfluoroalkyl substances (PFAS) serum levels among a group of New Jersey volunteer firefighters and comparison with the US National Health and Nutrition Examination Survey (NHANES) (2015-16)

  2020cites this paper
• Suggestions for Improving the Characterization of Risk from Exposures to Per and Polyfluorinated Alkyl Substances

  2020cites this paper
• Improving Health Risk Assessment as a Basis for Public Health Decisions in the 21st Century

  2020cites this paper
• Association between exposure to perfluoroalkyl substances and metabolic syndrome and related outcomes among older residents living near a Science Park in Taiwan.

  2020cites this paper
• Recent US State and Federal Drinking Water Guidelines for Per‐ and Polyfluoroalkyl Substances

  2020cites this paper
• Analysis of 58 poly-/perfluoroalkyl substances and their occurrence in surface water in a high-technology industrial park.

  2020cites this paper
• Exposure characteristics for congeners, isomers, and enantiomers of perfluoroalkyl substances in mothers and infants.

  2020cites this paper
• Distribution and effects of branched versus linear isomers of PFOA, PFOS, and PFHxS: A review of recent literature.

  2020cites this paper
• Per- and polyfluoroalkyl substances and blood pressure in pre-diabetic adults-cross-sectional and longitudinal analyses of the diabetes prevention program outcomes study.

  2020cites this paper
• DWGB Drinking Water Quality Manager New Hampshire Department of Environmental Services

  2019cites this paper
• The Road to Developing Maximum Contaminant Levels (MCLs) for Four PFAS: Lessons Learned from the New Hampshire Perspective

  2019cites this paper
• Associations between repeated measure of plasma perfluoroalkyl substances and cardiometabolic risk factors.

  2019cites this paper
• Measuring Total PFASs in Water: The Tradeoff between Selectivity and Inclusivity.

  2019cites this paper
• The association between perfluoroalkyl substances and lipids in cord blood.

  2019cites this paper
• Liver function biomarkers disorder is associated with exposure to perfluoroalkyl acids in adults: Isomers of C8 Health Project in China.

  2019cites this paper
• Per- and Polyfluoroalkyl Substances: A National Priority for Safe Drinking Water

  2019cites this paper
• Guideline levels for PFOA and PFOS in drinking water: the role of scientific uncertainty, risk assessment decisions, and social factors

  2019cites this paper
• Dose Effects of Ammonium Perfluorooctanoate on Lipoprotein Metabolism in APOE*3-Leiden.CETP Mice

  2019influential citation
• Evidences for replacing legacy per- and polyfluoroalkyl substances with emerging ones in Fen and Wei River basins in central and western China.

  2019cites this paper
• Per- and polyfluoroalkyl substances in human breast milk and current analytical methods

  2018cites this paper
• Perfluorooctane sulfonate precursors as indirect sources of internal exposure to perfluorooctane sulfonate (PFOS)

  2018cites this paper
• Evaluation and Management Strategies for Per- and Polyfluoroalkyl Substances (PFASs) in Drinking Water Aquifers: Perspectives from Impacted U.S. Northeast Communities

  2018cites this paper
• Associations between lipid/lipoprotein levels and perfluoroalkyl substances among US children aged 6-11 years.

  2018cites this paper
• Perfluoroalkyl Substances in the Environment

  2018cites this paper
• Reproductive and developmental toxicity of potassium perfluorohexanesulfonate in CD-1 mice.

  2018cites this paper
• Determination of perfluoroalkyl acid isomers in biosolids, biosolids-amended soils and plants using ultra-high performance liquid chromatography tandem mass spectrometry.

  2018cites this paper
• Stochastic Pharmacokinetic-Pharmacodynamic Modeling for Assessing the Systemic Health Risk of Perfluorooctanoate (PFOA)

  2018cites this paper
• Economic assessment and valuations of environmental and health impacts caused by Perfluorooctanoic acid (PFOA) and its salts

  2018cites this paper
• Betekenis resultaten bloedonderzoek PFOA omwonenden DuPont/Chemours

  2017cites this paper
• Toxicological Differences Between Perfluoroalkyl Substances (PFAS) Isomers Using Developmental Biomarkers

  2017influential citation
• Perfluoroalkyl substances with isomer analysis in umbilical cord serum in China

  2017cites this paper
• Isomers of perfluorooctanesulfonate (PFOS) in cord serum and birth outcomes in China: Guangzhou Birth Cohort Study.

  2017cites this paper
• Isomer-Specific Transplacental Transfer of Perfluoroalkyl Acids: Results from a Survey of Paired Maternal, Cord Sera, and Placentas.

  2017cites this paper
• Gender-specific associations between serum isomers of perfluoroalkyl substances and blood pressure among Chinese: Isomers of C8 Health Project in China.

  2017cites this paper
• Isomer-Specific Transplacental Efficiencies of Perfluoroalkyl Substances in Human Whole Blood

  2017cites this paper
• Recent experimental results of effects of perfluoroalkyl substances in laboratory animals - Relation to current regulations and guidance values.

  2017cites this paper
• Do levels of per- and polyfluorinated alkylated substances (PFASs) in snow bunting eggs increase with proximity to airports in Svalbard?

  2017cites this paper
• Perfluorooctane sulfonate affects proliferation and differentiation of pluripotent human teratocarcinoma cells

  2016cites this paper
• Bioaccumulation of perfluoroalkyl acids including the isomers of perfluorooctane sulfonate in carp (Cyprinus carpio) in a sediment/water microcosm

  2016cites this paper
• Isomer-Specific Distribution of Perfluoroalkyl Substances in Blood.

  2016cites this paper
• Impacts of daily intakes on the isomeric profiles of perfluoroalkyl substances (PFASs) in human serum.

  2016cites this paper
• Identification, Tissue Distribution, and Bioaccumulation Potential of Cyclic Perfluorinated Sulfonic Acids Isomers in an Airport Impacted Ecosystem.

  2016cites this paper
• Comment on “Hypercholesterolemia with consumption of PFOA-laced Western diets is dependent on strain and sex of mice” by Rebholz S.L. et al. Toxicol. Rep. 2016 (3) 46–54

  2016cites this paper
• Case study from SEURAT-1 : Perfluoroalkyl acids : direct acting toxicant category supported by SEURAT-1 data

  2016cites this paper
• Regulation of Reverse Cholesterol Transport by Micrornas and impact of Diet and Xenobiotics.

  2015influential citation
• Serum perfluorooctanoic acid (PFOA) concentrations in normal and hyperlipidemic female hamsters dosed orally with ammonium perfluorooctanoate (APFO) for up to 30 days

  2015cites this paper
• Perfluoroalkylated substances : PFOA , PFOS and PFOSA

  2015cites this paper
• Isomer-specific trophic transfer of perfluorocarboxylic acids in the marine food web of Liaodong Bay, North China.

  2015cites this paper
• Isomer-Specific Binding Affinity of Perfluorooctanesulfonate (PFOS) and Perfluorooctanoate (PFOA) to Serum Proteins.

  2015cites this paper
• Dosimetric Anchoring of Toxicological Studies

  2015cites this paper
• Perfluorooctane sulfonate: a review of human exposure, biomonitoring and the environmental forensics utility of its chirality and isomer distribution.

  2015cites this paper
• Prenatal exposures to perfluoroalkyl acids and serum lipids at ages 7 and 15 in females.

  2015cites this paper
• University of Birmingham Perfluorooctane sulfonate

  2015cites this paper
• Isomeric specific partitioning behaviors of perfluoroalkyl substances in water dissolved phase, suspended particulate matters and sediments in Liao River Basin and Taihu Lake, China.

  2015cites this paper
• Perfluoroalkyl and Polyfluoroalkyl Substances (PFASs) Affect the Thyroid Hormone System, Body Condition, and Body Mass in Two Arctic Seabird Species

  2015cites this paper
• Human Health Risk Assessment of Perfluoroalkyl Acids

  2015cites this paper
• Hypercholesterolemia with consumption of PFOA-laced Western diets is dependent on strain and sex of mice

  2015cites this paper